MedPath

EMERALD THERAPEUTICS, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

Meloxicam

Approval Date
Jan 25, 2024
FDA

Diflorasone Diacetate

Approval Date
Oct 1, 2021
FDA

Niacin

Approval Date
Apr 7, 2021
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.